O	O	0	12	Lactobacilli	Lactobacilli	B-NP	NN	O	5	NMOD	O
O	O	13	16	and	and	I-NP	CC	O	5	NMOD	O
O	O	17	24	vaginal	vaginal	I-NP	JJ	O	5	NMOD	O
O	O	25	29	host	host	I-NP	NN	O	5	NMOD	O
O	O	30	37	defense	defense	I-NP	NN	O	7	NMOD	O
O	O	37	38	:	:	O	:	O	5	P	O
O	O	39	49	activation	activation	B-NP	NN	O	0	ROOT	O
O	O	50	52	of	of	B-PP	IN	O	7	NMOD	O
O	O	53	56	the	the	B-NP	DT	O	17	NMOD	O
T6	B-Entity	57	62	human	human	I-NP	JJ	B-DNA	17	NMOD	B-DNA
T6	I-Entity	63	79	immunodeficiency	immunodeficiency	I-NP	NN	I-DNA	17	NMOD	I-DNA
T6	I-Entity	80	85	virus	virus	I-NP	NN	I-DNA	17	NMOD	I-DNA
T6	I-Entity	86	90	type	type	I-NP	NN	I-DNA	17	NMOD	I-DNA
T6	I-Entity	91	92	1	1	I-NP	CD	I-DNA	17	NMOD	I-DNA
T6	I-Entity	93	97	long	long	I-NP	JJ	I-DNA	17	NMOD	I-DNA
T6	I-Entity	98	106	terminal	terminal	I-NP	JJ	I-DNA	17	NMOD	I-DNA
T6	I-Entity	107	113	repeat	repeat	I-NP	NN	I-DNA	25	NMOD	I-DNA
O	O	113	114	,	,	O	,	O	25	P	O
O	O	115	123	cytokine	cytokine	B-NP	NN	B-protein	20	NMOD	B-protein
O	O	124	134	production	production	I-NP	NN	O	25	NMOD	O
O	O	134	135	,	,	O	,	O	25	P	O
O	O	136	139	and	and	O	CC	O	25	NMOD	O
T7	B-Entity	140	142	NF	NF	B-NP	NN	B-protein	25	NMOD	B-protein
T7	I-Entity	142	143	-	-	B-NP	HYPH	I-protein	25	NMOD	I-protein
T7	I-Entity	143	149	kappaB	kappaB	I-NP	NN	I-protein	8	PMOD	I-protein
O	O	149	150	.	.	O	.	O	7	P	O

O	O	152	164	Lactobacilli	Lactobacilli	B-NP	NNP	O	11	VMOD	O
O	O	164	165	,	,	O	,	O	11	P	O
O	O	166	167	a	a	B-NP	DT	O	4	NMOD	O
O	O	168	177	component	component	I-NP	NN	O	11	VMOD	O
O	O	178	180	of	of	B-PP	IN	O	4	NMOD	O
O	O	181	184	the	the	B-NP	DT	O	9	NMOD	O
O	O	185	191	normal	normal	I-NP	JJ	O	9	NMOD	O
O	O	192	199	vaginal	vaginal	I-NP	JJ	O	9	NMOD	O
O	O	200	205	flora	flora	I-NP	NN	O	5	PMOD	O
O	O	205	206	,	,	O	,	O	11	P	O
O	O	207	210	can	can	B-VP	MD	O	0	ROOT	O
O	O	211	219	activate	activate	I-VP	VB	O	11	VC	O
O	O	220	223	the	the	B-NP	DT	O	24	NMOD	O
T8	B-Entity	224	229	human	human	I-NP	JJ	B-DNA	24	NMOD	B-DNA
T8	I-Entity	230	246	immunodeficiency	immunodeficiency	I-NP	NN	I-DNA	24	NMOD	I-DNA
T8	I-Entity	247	252	virus	virus	I-NP	NN	I-DNA	24	NMOD	I-DNA
T8	I-Entity	253	254	(	(	O	(	I-DNA	19	DEP	I-DNA
T8	I-Entity	254	257	HIV	HIV	B-NP	NN	I-DNA	19	DEP	I-DNA
T8	I-Entity	257	258	)	)	O	)	I-DNA	16	NMOD	I-DNA
T8	I-Entity	258	259	-	-	B-NP	HYPH	I-DNA	24	NMOD	I-DNA
T8	I-Entity	259	260	1	1	I-NP	CD	I-DNA	24	NMOD	I-DNA
T8	I-Entity	261	265	long	long	I-NP	JJ	I-DNA	24	NMOD	I-DNA
T8	I-Entity	266	274	terminal	terminal	I-NP	JJ	I-DNA	24	NMOD	I-DNA
T8	I-Entity	275	281	repeat	repeat	I-NP	NN	I-DNA	12	OBJ	I-DNA
O	O	282	283	(	(	O	(	O	27	DEP	O
T9	B-Entity	283	286	LTR	LTR	B-NP	NN	B-DNA	27	DEP	B-DNA
O	O	286	287	)	)	O	)	O	24	NMOD	O
O	O	288	290	in	in	B-PP	IN	O	24	NMOD	O
O	O	291	294	the	the	B-NP	DT	O	39	NMOD	O
O	O	295	301	Jurkat	Jurkat	I-NP	NN	B-cell_line	32	NMOD	B-cell_line
O	O	302	303	T	T	I-NP	NN	I-cell_line	32	NMOD	I-cell_line
O	O	304	314	lymphocyte	lymphocyte	I-NP	NN	I-cell_line	39	NMOD	I-cell_line
O	O	315	318	and	and	I-NP	CC	O	39	NMOD	O
O	O	319	322	THP	THP	I-NP	NN	B-cell_line	39	NMOD	B-cell_line
O	O	322	323	-	-	B-NP	HYPH	I-cell_line	39	NMOD	I-cell_line
O	O	323	324	1	1	I-NP	CD	I-cell_line	39	NMOD	I-cell_line
O	O	325	335	macrophage	macrophage	I-NP	NN	I-cell_line	39	NMOD	I-cell_line
O	O	336	340	cell	cell	I-NP	NN	I-cell_line	39	NMOD	I-cell_line
O	O	341	346	lines	line	I-NP	NNS	I-cell_line	28	PMOD	I-cell_line
O	O	346	347	.	.	O	.	O	11	P	O

O	O	348	358	Activation	Activation	B-NP	NN	O	8	SUB	O
O	O	359	361	of	of	B-PP	IN	O	1	NMOD	O
O	O	362	365	the	the	B-NP	DT	O	4	NMOD	O
T10	B-Entity	366	369	LTR	LTR	I-NP	NN	B-DNA	2	PMOD	B-DNA
O	O	370	372	in	in	B-PP	IN	O	1	NMOD	O
O	O	373	379	Jurkat	Jurkat	B-NP	NN	B-cell_line	7	NMOD	B-cell_line
O	O	380	385	cells	cell	I-NP	NNS	I-cell_line	5	PMOD	I-cell_line
O	O	386	389	was	be	B-VP	VBD	O	0	ROOT	O
O	O	390	398	strongly	strongly	I-VP	RB	O	8	VMOD	O
O	O	399	407	enhanced	enhance	I-VP	VBN	O	8	VC	O
O	O	408	410	by	by	B-PP	IN	O	10	VMOD	O
O	O	411	419	vanadate	vanadate	B-NP	NN	O	11	PMOD	O
O	O	420	423	and	and	O	CC	O	10	VMOD	O
O	O	424	433	inhibited	inhibit	B-VP	VBN	O	10	VMOD	O
O	O	434	436	by	by	B-PP	IN	O	14	VMOD	O
T1	B-Protein	437	445	catalase	catalase	B-NP	NN	B-protein	15	PMOD	B-protein
O	O	445	446	,	,	O	,	O	10	P	O
O	O	447	458	implicating	implicate	B-VP	VBG	O	10	VMOD	O
O	O	459	463	H2O2	H2O2	B-NP	NN	O	18	OBJ	O
O	O	463	464	.	.	O	.	O	8	P	O

O	O	465	467	In	In	B-PP	IN	O	10	VMOD	O
O	O	468	476	contrast	contrast	B-NP	NN	O	1	PMOD	O
O	O	476	477	,	,	O	,	O	10	P	O
O	O	478	488	activation	activation	B-NP	NN	O	10	SUB	O
O	O	489	491	in	in	B-PP	IN	O	4	NMOD	O
O	O	492	495	THP	THP	B-NP	NN	B-cell_line	9	NMOD	B-cell_line
O	O	495	496	-	-	B-NP	HYPH	I-cell_line	9	NMOD	I-cell_line
O	O	496	497	1	1	I-NP	CD	I-cell_line	9	NMOD	I-cell_line
O	O	498	503	cells	cell	I-NP	NNS	I-cell_line	5	PMOD	I-cell_line
O	O	504	512	occurred	occur	B-VP	VBD	O	0	ROOT	O
O	O	513	515	in	in	B-PP	IN	O	10	VMOD	O
O	O	516	519	the	the	B-NP	DT	O	13	NMOD	O
O	O	520	527	absence	absence	I-NP	NN	O	11	PMOD	O
O	O	528	530	of	of	B-PP	IN	O	13	NMOD	O
O	O	531	539	vanadate	vanadate	B-NP	NN	O	14	PMOD	O
O	O	540	543	and	and	O	CC	O	10	VMOD	O
O	O	544	547	was	be	B-VP	VBD	O	10	VMOD	O
O	O	548	558	unaffected	unaffected	B-ADJP	JJ	O	17	VC	O
O	O	559	561	by	by	B-PP	IN	O	18	VMOD	O
T2	B-Protein	562	570	catalase	catalase	B-NP	NN	B-protein	19	PMOD	B-protein
O	O	570	571	.	.	O	.	O	10	P	O

O	O	572	575	The	The	B-NP	DT	O	3	NMOD	O
O	O	576	582	active	active	I-NP	JJ	O	3	NMOD	O
O	O	583	591	material	material	I-NP	NN	O	4	SUB	O
O	O	592	603	partitioned	partition	B-VP	VBD	O	0	ROOT	O
O	O	604	608	into	into	B-PP	IN	O	4	VMOD	O
O	O	609	612	the	the	B-NP	DT	O	8	NMOD	O
O	O	613	619	phenol	phenol	I-NP	NN	O	8	NMOD	O
O	O	620	625	layer	layer	I-NP	NN	O	5	PMOD	O
O	O	626	628	on	on	B-PP	IN	O	4	VMOD	O
O	O	629	632	hot	hot	B-NP	JJ	O	13	NMOD	O
O	O	633	640	aqueous	aqueous	I-NP	JJ	O	13	NMOD	O
O	O	641	647	phenol	phenol	I-NP	NN	O	13	NMOD	O
O	O	648	658	extraction	extraction	I-NP	NN	O	9	PMOD	O
O	O	658	659	.	.	O	.	O	4	P	O

O	O	660	672	Lactobacilli	Lactobacilli	B-NP	NNP	O	3	SUB	O
O	O	673	677	also	also	B-ADVP	RB	O	3	VMOD	O
O	O	678	687	increased	increase	B-VP	VBD	O	0	ROOT	O
T3	B-Protein	688	693	tumor	tumor	B-NP	NN	B-protein	6	NMOD	B-protein
T3	I-Protein	694	702	necrosis	necrosis	I-NP	NN	I-protein	6	NMOD	I-protein
T3	I-Protein	703	709	factor	factor	I-NP	NN	I-protein	11	NMOD	I-protein
T3	I-Protein	709	710	-	-	B-NP	HYPH	O	11	NMOD	O
T3	I-Protein	710	718	alphaand	alphaand	I-NP	NN	B-protein	9	NMOD	B-protein
T4	I-Protein	719	730	interleukin	interleukin	I-NP	NN	I-protein	11	NMOD	I-protein
T4	I-Protein	730	731	-	-	B-NP	HYPH	O	11	NMOD	O
T4	I-Protein	731	746	1betaproduction	1betaproduction	I-NP	NN	O	16	NMOD	O
O	O	747	750	and	and	O	CC	O	16	NMOD	O
O	O	751	760	activated	activate	B-NP	VBN	O	16	NMOD	O
T11	B-Entity	761	763	NF	NF	I-NP	NN	B-protein	16	NMOD	B-protein
T11	I-Entity	763	764	-	-	B-NP	HYPH	I-protein	16	NMOD	I-protein
T11	I-Entity	764	770	kappaB	kappaB	I-NP	NN	I-protein	3	OBJ	I-protein
O	O	771	773	in	in	B-PP	IN	O	16	NMOD	O
O	O	774	777	THP	THP	B-NP	NN	B-cell_line	21	NMOD	B-cell_line
O	O	777	778	-	-	B-NP	HYPH	I-cell_line	21	NMOD	I-cell_line
O	O	778	779	1	1	I-NP	CD	I-cell_line	21	NMOD	I-cell_line
O	O	780	785	cells	cell	I-NP	NNS	I-cell_line	17	PMOD	I-cell_line
O	O	786	789	and	and	O	CC	O	3	VMOD	O
O	O	790	799	increased	increase	B-NP	VBN	O	28	NMOD	O
T5	B-Protein	800	805	tumor	tumor	I-NP	NN	B-protein	26	NMOD	B-protein
T5	I-Protein	806	814	necrosis	necrosis	I-NP	NN	I-protein	26	NMOD	I-protein
T5	I-Protein	815	821	factor	factor	I-NP	NN	I-protein	28	NMOD	I-protein
T5	I-Protein	821	822	-	-	O	HYPH	O	28	P	O
T5	I-Protein	822	837	alphaproduction	alphaproduction	B-NP	NN	O	3	VMOD	O
O	O	838	840	by	by	B-PP	IN	O	28	NMOD	O
O	O	841	846	human	human	B-NP	JJ	B-cell_type	31	NMOD	B-cell_type
O	O	847	856	monocytes	monocyte	I-NP	NNS	I-cell_type	29	PMOD	I-cell_type
O	O	856	857	.	.	O	.	O	3	P	O

O	O	858	863	Human	Human	B-NP	JJ	O	4	NMOD	O
O	O	864	871	vaginal	vaginal	I-NP	JJ	O	4	NMOD	O
O	O	872	877	fluid	fluid	I-NP	NN	O	4	NMOD	O
O	O	878	887	specimens	specimen	I-NP	NNS	O	5	SUB	O
O	O	888	891	had	have	B-VP	VBD	O	0	ROOT	O
O	O	892	902	comparable	comparable	B-NP	JJ	O	7	NMOD	O
O	O	903	913	properties	property	I-NP	NNS	O	5	OBJ	O
O	O	913	914	,	,	O	,	O	5	P	O
O	O	915	920	which	which	B-NP	WDT	O	5	VMOD	O
O	O	921	931	correlated	correlate	B-VP	VBD	O	9	SBAR	O
O	O	932	936	with	with	B-PP	IN	O	10	VMOD	O
O	O	937	942	their	their	B-NP	PRP$	O	14	NMOD	O
O	O	943	952	bacterial	bacterial	I-NP	JJ	O	14	NMOD	O
O	O	953	960	content	content	I-NP	NN	O	11	PMOD	O
O	O	960	961	.	.	O	.	O	5	P	O

O	O	962	967	These	These	B-NP	DT	O	2	NMOD	O
O	O	968	976	findings	finding	I-NP	NNS	O	3	SUB	O
O	O	977	984	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	985	988	the	the	B-NP	DT	O	5	NMOD	O
O	O	989	997	presence	presence	I-NP	NN	O	3	OBJ	O
O	O	998	1000	in	in	B-PP	IN	O	5	NMOD	O
O	O	1001	1008	vaginal	vaginal	B-NP	JJ	O	8	NMOD	O
O	O	1009	1014	fluid	fluid	I-NP	NN	O	6	PMOD	O
O	O	1015	1017	of	of	B-PP	IN	O	8	NMOD	O
O	O	1018	1023	agent	agent	B-NP	NN	O	12	NMOD	O
O	O	1023	1024	(	(	O	(	O	12	NMOD	O
O	O	1024	1025	s	s	B-NP	NNS	O	33	NMOD	O
O	O	1025	1026	)	)	O	)	O	12	NMOD	O
O	O	1027	1034	derived	derive	B-VP	VBN	O	12	NMOD	O
O	O	1035	1039	from	from	B-PP	IN	O	14	VMOD	O
O	O	1040	1050	indigenous	indigenous	B-NP	JJ	O	17	NMOD	O
O	O	1051	1059	bacteria	bacteria	I-NP	NNS	O	15	PMOD	O
O	O	1060	1064	that	that	B-NP	WDT	O	17	NMOD	O
O	O	1065	1068	can	can	B-VP	MD	O	18	SBAR	O
O	O	1069	1077	activate	activate	I-VP	VB	O	19	VC	O
O	O	1078	1081	the	the	B-NP	DT	O	25	NMOD	O
T12	B-Entity	1082	1085	HIV	HIV	I-NP	NN	B-DNA	25	NMOD	B-DNA
T12	I-Entity	1085	1086	-	-	B-NP	HYPH	I-DNA	25	NMOD	I-DNA
T12	I-Entity	1086	1087	1	1	I-NP	CD	I-DNA	25	NMOD	I-DNA
T12	I-Entity	1088	1091	LTR	LTR	I-NP	NN	I-DNA	20	OBJ	I-DNA
O	O	1091	1092	,	,	O	,	O	33	P	O
O	O	1093	1101	cytokine	cytokine	B-NP	NN	B-protein	28	NMOD	B-protein
O	O	1102	1112	production	production	I-NP	NN	O	33	NMOD	O
O	O	1112	1113	,	,	O	,	O	33	P	O
O	O	1114	1117	and	and	O	CC	O	33	NMOD	O
T13	B-Entity	1118	1120	NF	NF	B-NP	NN	B-protein	33	NMOD	B-protein
T13	I-Entity	1120	1121	-	-	B-NP	HYPH	I-protein	33	NMOD	I-protein
T13	I-Entity	1121	1127	kappaB	kappaB	I-NP	NN	I-protein	9	PMOD	I-protein
O	O	1128	1130	in	in	B-PP	IN	O	5	NMOD	O
O	O	1131	1136	cells	cell	B-NP	NNS	O	34	PMOD	O
O	O	1137	1139	of	of	B-PP	IN	O	35	NMOD	O
O	O	1140	1150	macrophage	macrophage	B-NP	NN	B-cell_type	38	NMOD	B-cell_type
O	O	1151	1158	lineage	lineage	I-NP	NN	I-cell_type	36	PMOD	I-cell_type
O	O	1158	1159	,	,	O	,	O	3	P	O
O	O	1160	1164	with	with	B-PP	IN	O	3	VMOD	O
O	O	1165	1173	possible	possible	B-NP	JJ	O	42	NMOD	O
O	O	1174	1183	influence	influence	I-NP	NN	O	40	PMOD	O
O	O	1184	1186	on	on	B-PP	IN	O	42	NMOD	O
O	O	1187	1194	vaginal	vaginal	B-NP	JJ	O	45	NMOD	O
O	O	1195	1205	physiology	physiology	I-NP	NN	O	48	NMOD	O
O	O	1206	1209	and	and	O	CC	O	48	NMOD	O
O	O	1210	1214	host	host	B-NP	NN	O	48	NMOD	O
O	O	1215	1222	defense	defense	I-NP	NN	O	43	PMOD	O
O	O	1222	1223	.	.	O	.	O	3	P	O
